Public Company Innovation Hub

Join Cooley’s public companies group for our SEC Annual Reporting Workshop. More practical than ever before, this series features a number of interactive sessions focused on drafting various SEC disclosures, identifying pitfalls you need to avoid and offering the type of practical guidance that companies need to tackle another complicated proxy season.

Join Cooley lawyers Beth Sasfai, Emma Bichet and Michael Mencher as they discuss the major environmental, social and governance (ESG) topics that companies should be looking at in a rapidly evolving regulatory environment.

Join members of Cooley’s public companies and cyber/data/privacy groups as we analyze 8-K filing trends for cybersecurity incidents in the past year, offer strategies and considerations for companies when filing 8-Ks, and review our annual 8-K report covering these topics.

Cooley’s Comp Talks series is a program designed to address hot topics in executive, director and equity compensation specific to public companies. On November 13, join Cooley partners Scott McCall and Pete Adams as they discuss recent developments in mega grant equity compensation awards given to controlling shareholder executives – and the corporate governance matters that have arisen and continue to arise as a result.

The Securities and Exchange Commission (SEC) adopted final rules and form amendments intended to improve access to and management of accounts on its Electronic Data Gathering, Analysis, and Retrieval (EDGAR) system that are related to certain technical changes to EDGAR (collectively referred to as EDGAR Next). EDGAR Next will impact, most notably, public company and investment fund administrators, individuals (Section 16 officers and directors) and filing agents. Early coordination among these parties – well in advance of the September 15, 2025, compliance deadline – will be critical to ensure a smooth transition to EDGAR Next.

Learn more about the Securities and Exchange Commission adopting EDGAR Next, the SEC charging 23 entities with late filing violations, the SEC charging a company with misleading IPO investors about its market potential and sales prospects, the SEC charging a company and its former executives with misleading clinical trial claims, the SEC charging an independent director and former CEO with disclosure failures related to a personal relationship, Fidelity’s release of proxy voting guidelines, PCAOB’s report on auditor independence, California’s amended climate disclosure laws, the NYSE’s proposed rule change to limit use of reverse stock splits to regain compliance with price criteria, and the SEC’s approval of a Nasdaq rule change to modify application of bid price compliance periods.